Position as Postdoctoral Research Fellowship in pharmacoepidemiology and biostatistics is available at the Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.
The fellowship will be for a period of 3 years. Starting date as soon as possible.
The position is part of the PharmacoEpidemiology and Drug Safety Research Group at the Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo. The research group includes 4 full time researchers, 4 adjunct positions and over 10 PhD-students and post doc’s making up a group of more than 20 individuals. The PharmaSafe Research group at UiO is internationally recognized, with interests spanning a broad range of areas including pharmacoepidemiology, medication safety and clinical pharmacy, with special focus on vulnerable patient groups. The research group is multidisciplinary and has expertise within pharmacoepidemiology, biostatistics, genetics, psychiatry, pharmacotherapy and clinical pharmacy.
The candidate will be working on the IMI ConcepTION project, a collaborative European research project within the IMI (Innovative Medicines Initiative) program aimed at generating and disseminating evidence on the effects of medicines used in pregnancy and during lactation. The background for this large European project is the lack of knowledge about safety of prenatal exposure to medication.
The post doc will be involved in several studies using advanced statistics and causal inference methods to study associations between medication use during pregnancy and pregnancy outcomes. One study will specifically aim to study the safety of antimigraine medications in pregnancy. Focus will also be on maternal health outcomes (e.g. preeclampsia) in pregnancy. The epidemiological data consists of data from various secondary data sources such as prescription data, patient registries and medical birth registries from several European countries. The candidate will also be involved in one human lactation study.
The candidate will also be included in the PharmaTox Strategic Research Initiative at the Faculty of Mathematics and Natural Sciences, University of Oslo. PharmaTox is a multidisciplinary center comprising strong research environments in pharmaceutical bioscience, biology, bioinformatics and statistics.
The Faculty of Mathematics and Natural Sciences has a strategic ambition of being a leading research faculty. Candidates for these fellowships will be selected in accordance with this, and expected to be in the upper segment of their class with respect to academic credentials.
Applicants must hold a degree equivalent to a Norwegian doctoral degree in epidemiology or biostatistics. Doctoral dissertation must be submitted for evaluation by the closing date. Only applicants with an approved doctoral thesis and public defense are eligible for appointment
Competence in the application of advanced epidemiological and causal inference methods
Research experience within pharmacoepidemiology and analysis of large-scale data sets
Fluent oral and written communication skills in English
The following qualifications will count in the assessment of the applicants:
Good computational and coding skills (e.g. STATA, R, SAS)
High motivation for a research career, documented primarily via original publications in peer-reviewed scientific journals
Ability to work independently as well as in multidisciplinary teams
Ability to give and receive constructive scientific criticism
Resourceful, structured, and results-oriented
The application must include:
Cover letter (statement of motivation, summarizing scientific work and research interest)
CV (summarizing education, positions, pedagogical experience, administrative experience and other qualifying activity)
Copies of educational certificates, academic transcript of records and letters of recommendation
A complete list of publications and up to 5 academic works that the applicant wishes to be considered by the evaluation committee
Names and contact details of 2-3 references (name, relation to candidate, e-mail and telephone number)
The application with attachments must be delivered in our electronic recruiting system. Foreign applicants are advised to attach an explanation of their University's grading system. Please note that all documents should be in English (or a Scandinavian language).
In assessing the applications, special emphasis will be placed on the documented, academic qualifications, the project description (whenever this is required in the call for applicants), and the quality of the project as well as the candidates motivation and personal suitability. Interviews with the best qualified candidates will be arranged. It is expected that the successful candidate will be able to complete the project in the course of the period of employment.
Contact information For further information please contact Professor Hedvig Nordeng, phone: +47 22856604, e-mail: email@example.com
Internal Number: 1-2020
About University of Oslo
The PharmacoEpidemiology & Drug Safety Research Group covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, statistics, health economics and pharmacotherapy.